Talk to Sam
+1 718 473 0872
Search inside this page
Free Market Research Guides to Download
» View Public Reports39 reports
... Of simon penney 11-oct-13 msb mesoblast acquires stem cell therapeutics business from us-based osiris in $50m cash and scrip deal source: iress changes in substantial holdings previous new date code company ...
» Purchase Premium Reports (From $ 125 - $ 3 500)10 reports
Summary Chemokine Therapeutics Corp. (Chemokine Therapeutics) is a publicly held biotechnology company. It is engaged in the discovery and develops peptide analogs of chemokines for cancer treatment and ...
Reportlinker.com © Copyright 2013. All rights reserved.